Cell fusion studies to examine the mechanism for etoposide resistance in Chinese hamster V79 spheroids

Experimental Cell Research

Volumn 243, Issue 2, 1998, Pages 282-289

  Luo, C ^a   Johnston, P J ^a   MacPhail, S H ^a   Banath J P ^a   Oloumi, A ^a   Olive, P L ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE;

ANIMAL CELL; ARTICLE; CELL FUSION; CHINESE HAMSTER; CONTROLLED STUDY; DNA STRAND BREAKAGE; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; FLUORESCENCE ACTIVATED CELL SORTER; NONHUMAN; PRIORITY JOURNAL; SPHEROID CELL;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0032531141     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4170     Document Type: Article

References (22)

1. Olive P. L., Banáth J. P., Evans H. H. Cell killing and DNA damage by etoposide in Chinese hamster V79 monolayers and spheroids: Influence of growth kinetics, growth environment and DNA packaging. Br. J. Cancer. 67:1993;522-530.
2. Wilson W. R., Whitmore G. F., Hill R. P. Activity of 4′-(9-acridinylamino)methanesulfon-m-anisdide against Chinese hamster cells in multicell spheroids. Cancer Res. 41:1981;2817-2822.
3. Adachi Y., Käs E., Laemmli U. K. Preferential, cooperative binding of DNA topoisomerase II to scaffold-associated regions. EMBO J. 8:1989;3997-4006.
4. Fernandes D. J., Catapano C. V. The nuclear matrix as a site of anticancer drug action. Inter. Rev. Cytol. 162A:1995;539-576.
5. Arndt-Jovin D. J., Udvardy A., Garner M. M., Ritter S., Jovin T. M. Z-DNA binding and inhibition by GTP ofDrosophilia. Biochemistry. 32:1993;4862-4872.
6. Olive P. L., Durand R. E. Drug and radiation resistance in spheroids: Cell contact and kinetics. Cancer Metast. Rev. 13:1994;121-138.
7. Olive P. L., Hilton J., Durand R. E. DNA conformation of Chinese hamster V79 cells and sensitivity to ionising radiation. Radiat. Res. 107:1986;115-124.
8. Olive P. L. DNA organization affects cellular radiosensitivity and detection of initial DNA strand breaks. Int. J. Radiat. Biol. 62:1992;389-396.
9. Evans H. H., Ricanati M., Horng M., Mencl J. Relationship between topoisomerase II and radiosensitivity in L5178Y lymphoma strains. Mutat. Res. 217:1989;53-64.
10. Olive P. L., Banath J. P., Durand R. E. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay. Radiat. Res. 122:1990;69-72.
11. Ling V., Thompson L. H. Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J. Cell. Physiol. 83:1974;103-116.
12. Jaroszeski M. J., Gilbert R., Heller R. Detection and quantitation of cell-cell electrofusion products by flow cytometry. Anal. Biochem. 216:1994;271-275.
13. Beck W. T., Danks M. K., Wolverton J. S., Granzen B., Chen M., Schmidt C. A., Bugg B. Y., Friche E., Suttle D/P. Altered DNA topoisomerase II in multidrug resistance. Cytotechnology. 11:1993;115-119.
14. Whithoff S., De Jong S., De Vries E. G. E., Mulder N. H. Human DNA topoisomerase II: Biochemistry and role in chemotherapy resistance. Anticancer Res. 16:1996;1867-1880.
15. Ganapathi R., Constantinou A., Kamath N., Dubjak G., Grabowski D., Krivacic K. Resistance to etoposide in human leukemia HL-60 cells: Reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides. Mol. Pharmacol. 50:1996;243-248.
16. Ritke M. K., Murray N. R., Allan W. P., Fields A. P., Yalowich J. C. Hypophosphorylation of topoisomerase II in etoposide (VP-16) resistant human leukemia K562 cells associated with reduced levels of beta II protein kinase C. Mol. Pharmacol. 48:1995;798-805.
17. Chen M., Beck W. T. DNA topoisomerase II expression, stability, and phosphorylation in two VM-26 resistant human leukemic CEM sublines. Oncol. Res. 7:1995;103-111.
18. Kimura K., Nozaki N., Enomoto T., Tanaka M., Kikuchi A. Analysis of M phase-specific phosphorylation of DNA topoisomerase II. J. Biol. Chem. 271:1996;21439-21445.
19. Adachi N., Miyaike M., Kato S., Kanamaru R., Koyama H., Kikuchi A. Cellular distribution of mammalian DNA topoisomerase II is determined by its catalytically dispensable C-terminal domain. Nucleic Acids Res. 25:1997;3135-3142.
20. Gordon D. J., Milner A. W., Beaney R. P., Gridina D. J., Vaughan A. T. The increase in radioresistance of Chinese hamster cells cultured as spheroids is correlated to changes in nuclear morphology. Radiat. Res. 121:1990;175-179.
21. Lamb N. J., Fernandez A., Watrin A., Labbe J-C., Cavadore J-C. Microinjection of p34cdc2 kinase induces marked changes in cell shape, cytoskeletal organization, and chromatin structure in mammalian fibroblasts. Cell. 60:1990;151-165.
22. Pines J. Cyclins and cyclin-dependent kinases: Theme and variations. Adv. Cancer Res. 66:1995;181-212.